On Thursday 07/18/2024 the closing price of the Chemed Corp. share was $542.11 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $545.59, this is a drop of 0.64%.
Chemed Corp.'s market capitalization is $8.31 B by 15.14 M shares outstanding.
Is Chemed stock a Buy, Sell or Hold?
Chemed stock has received a consensus rating of buy. The average rating score is and is based on 12 buy ratings, 0 hold ratings, and 0 sell ratings.What was the 52-week low for Chemed stock?
The low in the last 52 weeks of Chemed stock was 492.70. According to the current price, Chemed is 110.23% away from the 52-week low.What was the 52-week high for Chemed stock?
The high in the last 52 weeks of Chemed stock was 654.91. According to the current price, Chemed is 82.93% away from the 52-week high.What are analysts forecasts for Chemed stock?
The 12 analysts offering price forecasts for Chemed have a median target of 612.25, with a high estimate of 712.00 and a low estimate of 541.00. The median estimate represents a 88.70 difference from the last price of 543.09.Chemed Stock Snapshot
542.52
Bid
5.00
Bid Size
545.25
Ask
2.00
Ask Size
7/19/2024
Date
3:59 PM
Time
2,244.00
Volume
542.11
Prev. Close
545.59
Open
8.22 B
Market Cap in USD
15.14 M
Number of Shares
542.01
Day Low
545.59
Day High
543.09
492.70
52 Week Low
654.91
52 Week High
543.09
1.56
Dividend in USD
0.27
Dividend Yield
32.62
P/E Ratio
97.82
Free Float in %
18.11
EPS in USD
73.69
Book Value per Share in USD
21.73
Cash Flow per Share in USD
Chemed News More News
Historical Prices for Chemed
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Chemed Analyst Data
Total Analysts: 12
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 541.00
Median: 612.25
Highest: 712.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Chemed Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 05/21/24 | RBC Capital Markets | Maintained Buy | $697 | |||
| 03/04/24 | RBC Capital Markets | Maintained Buy | $712 | |||
| 02/29/24 | Oppenheimer & Co. Inc. | Maintained Buy | $650 | |||
| 01/17/24 | Oppenheimer & Co. Inc. | Maintained Buy | $625 | |||
| 10/30/23 | RBC Capital Markets | Maintained Buy | $604 | |||
| 07/31/23 | RBC Capital Markets | Maintained Buy | $576 | |||
| 07/27/23 | Oppenheimer & Co. Inc. | Maintained Buy | $590 | |||
| 05/01/23 | RBC Capital Markets | Maintained Buy | $610 | |||
| 04/28/23 | Oppenheimer & Co. Inc. | Maintained Buy | $610 | |||
| 02/27/23 | RBC Capital Markets | Maintained Buy | $587 | |||
| 11/03/22 | RBC Capital Markets | Maintained Buy | $545 | |||
| 08/01/22 | RBC Capital Markets | Maintained Buy | $541 |
Chemed Estimates* in USD
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| Revenue | 2,431 | 2,595 | 2,754 |
| Dividend | 1.64 | 1.72 | - |
| Dividend Yield (in %) | 0.30 % | 0.32 % | - |
| EPS | 23.21 | 25.28 | 26.61 |
| P/E Ratio | 23.40 | 21.49 | 20.41 |
| EBIT | 419 | 469 | 524 |
| EBITDA | 510 | 549 | 580 |
| Net Profit | 322 | 362 | 391 |
| Net Profit Adjusted | 355 | 386 | 405 |
| Pre-Tax Profit | 421 | 469 | 511 |
| Net Profit (Adjusted) | 409 | 457 | 483 |
| EPS (Non-GAAP) ex. SOE | 23.21 | 25.28 | 26.61 |
| EPS (GAAP) | 20.68 | 23.45 | 24.98 |
| Gross Income | 859 | 922 | 973 |
| Cash Flow from Investing | - | - | - |
| Cash Flow from Operations | 435 | 472 | 509 |
| Cash Flow from Financing | - | - | - |
| Cash Flow per Share | 25.13 | 28.32 | - |
| Free Cash Flow | 377 | 411 | 447 |
| Free Cash Flow per Share | - | - | - |
| Book Value per Share | - | - | - |
| Net Debt | -640 | -1,051 | -1,560 |
| Research & Development Exp. | - | - | - |
| Capital Expenditure | 58 | 61 | 62 |
| Selling, General & Admin. Exp. | 358 | 371 | 387 |
| Shareholder’s Equity | - | - | - |
| Total Assets | - | - | - |
|
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | 3 | 3 | 3 | 3 | 3 |
| Average Estimate | 5.593 USD | 5.887 USD | 6.537 USD | 23.210 USD | 25.277 USD |
| Year Ago | 3.545 USD | 4.972 USD | 5.964 USD | 18.107 USD | - |
| Publish Date | 7/24/2024 | 10/30/2024 | 2/25/2025 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | 3 | 3 | 3 | 4 | 4 |
| Average Estimate | 599 USD | 609 USD | 632 USD | 2,431 USD | 2,595 USD |
| Year Ago | 554 USD | 565 USD | 586 USD | 2,264 USD | - |
| Publish Date | 7/24/2024 | 10/30/2024 | 2/25/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales | 2,264.42 | 2,134.96 | 2,139.26 | 2,079.58 | 1,938.56 | 1,782.65 | 1,666.72 |
| Change of sales in % | 6.06 | -0.20 | 2.87 | 7.27 | 8.75 | 6.96 | 5.70 |
| Gross profit on sales | 737.95 | 705.91 | 710.75 | 644.80 | 572.22 | 515.14 | 480.57 |
| Gross profit on sales change in % | 4.54 | -0.68 | 10.23 | 12.68 | 11.08 | 7.19 | 12.59 |
| Operating income | 342.83 | 347.19 | 342.17 | 314.59 | 271.35 | 245.69 | 216.40 |
| Operating income change in % | -1.25 | 1.47 | 8.77 | 15.94 | 10.44 | 13.53 | 16.27 |
| Income before tax | 350.37 | 329.68 | 350.31 | 395.99 | 261.61 | 239.60 | 116.92 |
| Income before tax change in % | 6.28 | -5.89 | -11.53 | 51.37 | 9.19 | 104.93 | -33.97 |
| Income after tax | 272.51 | 249.62 | 268.55 | 319.47 | 219.92 | 205.54 | 98.18 |
| Income after tax change in % | 9.17 | -7.05 | -15.94 | 45.26 | 7.00 | 109.36 | -9.72 |
Balance Sheet in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 652.91 | 740.42 | 815.79 | 625.75 | 619.85 | 425.01 | 379.67 |
| Long-term liabilities per share | 22.67 | 29.80 | 34.43 | 20.53 | 22.43 | 14.70 | 11.61 |
| Equity | 1,107.88 | 798.72 | 623.27 | 901.20 | 726.61 | 591.33 | 540.35 |
| Equity change in % | 38.71 | 28.15 | -30.84 | 24.03 | 22.88 | 9.43 | 3.10 |
| Balance sheet total | 1,760.79 | 1,539.14 | 1,439.06 | 1,526.95 | 1,346.45 | 1,016.34 | 920.03 |
| Balance sheet total change in % | 14.40 | 6.95 | -5.76 | 13.41 | 32.48 | 10.47 | 4.54 |
Key Data in USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 148.97 | 141.40 | 134.22 | 126.82 | 117.30 | 106.09 | 99.55 |
| P/E ratio (year end quote, basic EPS) | 32.62 | 30.87 | 31.40 | 27.34 | 33.01 | 23.16 | 41.47 |
| P/E ratio (year end quote, diluted EPS) | 32.62 | 30.87 | 31.40 | 27.34 | 33.01 | 23.16 | 41.47 |
| P/E ratio (year end quote) | 32.62 | 30.87 | 31.40 | 27.34 | 33.01 | 23.16 | 41.47 |
| Dividend yield in % | 0.27 | 0.29 | 0.26 | 0.25 | 0.28 | 0.41 | 0.44 |
| Equity ratio in % | 62.92 | 51.89 | 43.31 | 59.02 | 53.96 | 58.18 | 58.73 |
| Debt ratio in % | 37.08 | 48.11 | 56.69 | 40.98 | 46.04 | 41.82 | 41.27 |
Chemed Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| GRACE PATRICK P | 06/11/2024 | 284.00 | 3,270.00 | 540.98 | Sell | No |
| MCNAMARA KEVIN J | 06/05/2024 | 1,500.00 | 107,049.00 | 544.17 | Sell | No |
| Heaney Christopher J | 05/19/2024 | 284.00 | 2,112.00 | 564.34 | Buy | No |
| RICE THOMAS P | 05/19/2024 | 284.00 | 6,028.00 | 564.34 | Buy | No |
| DeLyons Ron | 05/19/2024 | 284.00 | 1,389.00 | 564.34 | Buy | No |
| WALSH GEORGE J III | 05/19/2024 | 284.00 | 3,646.00 | 564.34 | Buy | No |
| Mount John Meredith Jr. | 05/19/2024 | 284.00 | 653.00 | 564.34 | Buy | No |
| LINDELL ANDREA R | 05/19/2024 | 284.00 | 6,556.00 | 564.34 | Buy | No |
| GRACE PATRICK P | 05/19/2024 | 284.00 | 3,554.00 | 564.34 | Buy | No |
| McCarthy Eileen P | 05/19/2024 | 284.00 | 578.00 | 564.34 | Buy | No |
| MCNAMARA KEVIN J | 05/15/2024 | 4,000.00 | 108,549.00 | 567.54 | Sell | No |
| Witzeman Michael D | 05/06/2024 | 921.00 | 3,061.00 | 576.95 | Sell | No |
| Witzeman Michael D | 05/06/2024 | 1,100.00 | 3,982.00 | 413.19 | Buy | No |
| LEE SPENCER S | 04/29/2024 | 1,133.00 | 19,627.00 | n/a | Sell | No |
| LEE SPENCER S | 03/27/2024 | 2,000.00 | 20,760.00 | 641.65 | Sell | No |
| LEE SPENCER S | 03/27/2024 | 7,080.00 | 26,680.00 | 643.78 | Sell | No |
| LEE SPENCER S | 03/27/2024 | 13,000.00 | 33,760.00 | 106.59 | Buy | No |
| Witzeman Michael D | 03/20/2024 | 2,650.00 | 2,882.00 | 643.14 | Sell | No |
| Judkins Brian C | 03/19/2024 | 11,158.00 | 1,422.00 | 645.00 | Sell | No |
| Witzeman Michael D | 03/19/2024 | 355.00 | 5,532.00 | 647.44 | Sell | No |
| Witzeman Michael D | 03/19/2024 | 2,600.00 | 5,887.00 | 413.19 | Buy | No |
| Judkins Brian C | 03/19/2024 | 6,133.00 | 12,580.00 | 471.74 | Buy | No |
| Judkins Brian C | 03/19/2024 | 5,825.00 | 6,447.00 | 413.19 | Buy | No |
| HUTTON THOMAS C | 03/05/2024 | 2,673.00 | 36,919.00 | 633.58 | Sell | No |
| HUTTON THOMAS C | 03/05/2024 | 1,267.00 | 37,592.00 | 413.19 | Buy | No |
Chemed Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | Chemed Corp. | 1.56 | 0.27 | USD |
| 2022 | Chemed Corp. | 1.48 | 0.29 | USD |
| 2021 | Chemed Corp. | 1.40 | 0.26 | USD |
| 2020 | Chemed Corp. | 1.32 | 0.25 | USD |
| 2019 | Chemed Corp. | 1.24 | 0.28 | USD |
| 2018 | Chemed Corp. | 1.16 | 0.41 | USD |
| 2017 | Chemed Corp. | 1.08 | 0.44 | USD |
| 2016 | Chemed Corp. | 1.00 | 0.62 | USD |
| 2015 | Chemed Corp. | 0.92 | 0.61 | USD |
| 2014 | Chemed Corp. | 0.84 | 0.79 | USD |
| 2013 | Chemed Corp. | 0.76 | 0.99 | USD |
| 2012 | Chemed Corp. | 0.68 | 0.99 | USD |
| 2011 | Chemed Corp. | 0.60 | 1.17 | USD |
| 2010 | Chemed Corp. | 0.52 | 0.82 | USD |
| 2009 | Chemed Corp. | 0.36 | 0.75 | USD |
*Yield of the Respective Date
Chemed Corp. Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | 5.593 USD | Q2 2024 Earnings Release | 07/24/2024 |
| Earnings Report | 5.887 USD | Q3 2024 Earnings Release | 10/30/2024 |
| Earnings Report | 6.537 USD | Q4 2024 Earnings Release | 02/25/2025 |
| Earnings Report | 5.835 USD | Q1 2025 Earnings Release | 04/29/2025 |
| Earnings Report | 6.140 USD | Q2 2025 Earnings Release | 07/23/2025 |
Chemed Corp. Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Annual General Meeting | - | Annual General Meeting | 05/20/2024 |
| Press Conference | - | - | 04/25/2024 |
Chemed Profile
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Moody’s Daily Credit Risk Score
Chemed Shareholder
| Owner | in % |
|---|---|
| Freefloat | 97.82 |
| The Vanguard Group, Inc. | 11.23 |
| Vanguard Group, Inc. (Subfiler) | 11.09 |
| BlackRock Fund Advisors | 5.55 |
| Durable Capital Partners LP | 3.77 |
| Kayne Anderson Rudnick Investment Management LLC | 3.74 |
| LB Hercules Holdings LLC | 3.38 |
| Vanguard Total Stock Market ETF | 3.13 |
| iShares Core S&P Mid Cap ETF | 3.11 |
| State Street Corp. | 3.09 |
| William Blair Investment Management LLC | 3.06 |
| BlackRock Institutional Trust Co. NA | 2.98 |
| Vanguard Small Cap Index Fund | 2.51 |
| Neuberger Berman Genesis Fund | 2.00 |
| Geode Capital Management LLC | 1.98 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.